Abstract
A phartnacokinetic/pharmacodynamic model describing receptor-mediated effects of prednisolone is presented. The basis of the model is the generally accepted mechanism of action of steroid hormones in which corticosteroids bind to cytosolic receptors forming steroid-receptor complexes, which are activated and translocated into the nucleus. There the complexes associate with specific DNA sequences and modulate the rate of transcription of DNA into specific RNAs that code for the synthesis of proteins that elicit biological responses. Prednisolone, 5 or 50 mg/kg, was administered intravenously to adrenalectomized rats. Total plasma, free plasma, CBG-free plasma, and liver prednisolone concentrations were measured simultaneously with free hepatic cytosolic glucocorticoid receptor concentrations and tyrosine aminotransferase (TAT) activity of the liver as a function of time. The association/dissociation kinetics of prednisolone binding to the glucocorticoid receptor were measured separately in vitroat 37°C. Total plasma, free plasma, and CBG-free plasma prednisolone concentrations could be used equally well in the model to account for the time course of receptor concentrations and TAT activity. However, use of liver steroid concentrations resulted in an overestimation of receptor depletion. Steroid concentrations in plasma increased 20 to 30-fold with a tenfold increase in dose, but receptor occupancy and TAT activity over time increased about threefold. While prednisolone pharmacokinetics were dose-dependent, parameters describing receptor kinetics and TAT activity were constant at each prednisolone dose. The major determinants of receptor-mediated glucocorticoid activity are confirmed to be the availability of the receptor, drug-receptor dissociation rate, and corticosteroid persistence in the biophase.
Similar content being viewed by others
References
G. Levy. Kinetics of pharmacologic effects.Clin. Pharmacol. Ther. 7:362–372 (1966).
E. J. Ariens. Drug levels in the target tissue and effect.Clin. Pharmacol. Ther. 16:155–175 (1974).
N. H. G. Holford and L. B. Sheiner. Pharmacokinetic and pharmacodynamic modelingin vivo.CRC Crit. Rev. Bioeng. 5:273–322 (1981).
B. Oosterhuis. R. J. M. Ten Berge, H. P. Sauerwein, E. Endert, P. T. A. Schellekens, and C. J. Van Boxtel. Pharmacokinetic-pharmacodynamic modeling of prednisolone induced lymphocytopenia in man.J. Pharmacol. Exp. Ther. 229:539–545 (1984).
L. K. Paalzow. Integrated pharmacokinetic-pharmacodynamic modeling of drugs acting on the CNS.Metab. Rev. 15:383–400 (1984).
M. L. Jack, W. A. Colburn, N. M. Spirt, G. Bautz, M. Zanko, W. D. Horst, and R. A. O'Brien. A pharmacokinetic/pharmacodynamic/receptor binding model to predict the onset and duration of pharmacological activity of the benzodiazepines.Prog. Neuropsychopharmacol. Biol. Psychiat. 7:629–635 (1983).
E. V. Jenson and H. I. Jacobson. Basic guides to the mechanism of estrogen action.Recent Prog. Horm. Res. 18:387–414 (1962).
J. D. Baxter and J. W. Funder. Hormone receptors.N. Engl. J. Med. 301:1149–1161 (1979).
A. Munck and K. Leung. In J. R. Pasqualini (ed.),Glucocorticoid Receptors and Mechanism of Action of Steroid Hormones, Marcel Dekker, New York, 1977, pp. 311–397.
M. Izawa, A. Yoshida, and S. Ichii. Dynamics of glucocorticoid receptor and induction of tyrosine aminotransferase in rat liver.Endocrinol. Japon. 29:209–218 (1982).
T. J. Schmidt and G. Litwack. Activation of the glucocorticoid-receptor complex.Physiol. Rev. 62:1131–1192 (1982).
G. G. Rousseau. Control of gene expression by glucocorticoid hormones.Biol. Chem. J. 225:1–12 (1984).
G. J. Blackwell, R. Carnuccio, M. DiRosa, R. J. Flower, L. Parente, and P. Pessico. Macrocortin: A polypeptide causing anti-phospholipase effect of glucocorticoids.Nature 287:147–149 (1980).
P. L. Ballard, J. D. Baxter, S. J. Higgins, G. G. Rousseau, and G. M. Tomkins. General presence of glucocorticoid receptors in mammalian tissues.Endocrinology 94:998–1002 (1974).
A. M. P. Saaverdra-Delgrado, K. P. Mathews, P. M. Pan, D. R. Kay, and M. L. Mulenberg. Dose response studies of the suppression of whole blood histamine and basophil counts of prednisone.J. Allergy Clin. Immunol. 66:464–471 (1980).
R. Ellul-Micallef and F. F. Fenech. Intravenous prednisolone in chronic bronchial asthma.Thorax 30:312–315 (1975).
H. Kitagawa, T. Mohri, and M. Kitagawa. Comparative studies on anti-inflammatory effect and biological fates of 21-phosphates and -sulfates of dexamethasone and prednisolone,Arzneim. Forsch. 22:402–410 (1972).
M. Kalimi, M. Beato, and P. Feigelson. Interaction of glucocorticoids with rat liver nuclei. I. Role of the cytosol proteins.Biochemistry 12:3365–3371 (1973).
C. R. Wira and A. Munck. Glucocorticoid-receptor complexes in rat thymus cells.J. Biol. Chem. 249:5328–5336 (1974).
F. Payvar, O. Wrange, J. Carlstedt-Duke, S. Okret, J.-A. Gustafsson, and K. R. Yamamoto. Purified glucocorticoid receptors binding selectivelyin vitro to a cloned DNA fragment whose transcription is regulated by glucocorticoidsin vivo.Proc. Natl. Acad. Sci. USA 78:6628–6632 (1981).
M. Pfahl. Specific binding of the glucocorticoid-receptor complex to the mouse mammary tumor proviral promotor region.Cell 31:475–482 (1982).
B. M. Raaka and H. H. Samuels. The glucocorticoid receptor in GH1 cells.J. Biol. Chem. 258:417–425 (1983).
S. Miyabe and R. W. Harrison.In vivo activation and nuclear binding of the ALT-20 mouse pituitary tumor cell glucocorticoid receptor.Endocrinology 112:2174–2180 (1983).
J. M. Nickol, K.-L. Lee, and F. T. Kenney. Changes in hepatic levels of tyrosine aminotransferase messenger RNA during induction by hydrocortisone.J. Biol. Chem. 253:4009–4015 (1978).
D. Granner, P. Olson, S. Seifert, C. Block, M. Diesterhaft, J. Hargrove, and T. Noguchi. Regulation of tyrosine aminotransferase mRNA in HTC cells.Ann. N. Y. Acad. Sci. 349:183–194 (1980).
J. Q. Rose and W. J. Jusko. Corticosteroid analysis in biological fluids by high-performance liquid chromatography.J. Chromatogr. 162:273–280 (1979).
N. Khalafallah and W. J. Jusko. Tissue distribution of prednisolone in the rabbit.J. Pharmacol. Exp. Ther. 229:719–725 (1984).
F. D. Boudinot and W. J. Jusko. Fluid shifts and other factors affecting plasma protein binding of prednisolone by equilibrium dialysis.J. Pharm. Sci. 73:774–780 (1984).
R. L. Priore and H. E. Rosenthal. A statistical method for the estimation of binding parameters in a complex system.Anal. Biochem. 70:231–240 (1976).
Packard Instrument Co., Instrument Manual 2136, Downers Grove, Illinois (1977).
N. Lui, R. R. Almon, and W. J. Jusko. Comparison of filtration and equilibrium dialysis methods for3H-imipramine binding to human platelets.Anal. Biochem. 139:42–57 (1984).
C. M. Metzler, G. K. Elfring, and A. J. McEwen. A package of computer programs for pharmacokinetic modeling.Biometrics 30:562–563 (1974).
T. I. Diamondstone. Assay of tyrosine transaminase activity by conversion ofp-hyroxyphenylpyruvate top-hydroxybenzaldehyde.Anal. Biochem. 16:395–401 (1966).
O. M. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randal. Protein measurement with the folin phenol reagent.J. Biol. Chem. 193:265–272 (1951).
F. D. Boudinot and W. J. Jusko. Dose dependent pharmacokinetics of prednisolone in normal and adrenalectomized rats.J. Pharmacokin. Biopharm. 14:453–467 (1986).
P. G. W. Plageman and J. Erbe. Glucocorticoids-uptake by simple diffusion by cultured Reuber and Novikoff rat hepatoma cells.Biochem. Pharmacol. 25:1489–1494 (1976).
W. M. Pardridge and L. J. Mietus. Transport of protein-bound steroid hormones into liverin vivo.Am. J. Physiol. 237:E367-E372 (1979).
S. R. Gross, L. Aronow, and W. B. Pratt. The active transport of cortisol of mouse fibroblasts growingin vitro.J. Cell. Biol. 44:103–114 (1970).
M. L. Rao, G. S. Rao, M. Holler, H. Breuer, P. J. Schattenberg, and W. D. Stein. Uptake of cortisol by isolated rat liver cells. A phenomenon indicative of carrier-mediation and simple diffusion.J. Physiol. Chem. 357:573–584 (1976).
J. F. Hackney, S. R. Gross, L. Aronow, and W. B. Pratt. Specific glucocorticoid-binding macromolecules from mouse fibroblasts growingin vitro.Mol. Pharmacol. 6:500–512 (1970).
N. Khalafallah and W. J. Jusko. Determination and prediction of tissue binding of prednisolone in the rabbit.J. Pharm. Sci. 73:362–366 (1984).
M. Mayer, N. Kaiser, R. J. Millholland, and F. Rosen. Cortisol binding in rat skeletal muscle.J. Biol. Chem. 250:1207–1210 (1975).
W. R. Slaunwhite, G. M. Lockie, N. Back, and A. A. Sandberg. Inactivityin vivo of transcortin bound cortisol.Science 135:1062–1063 (1962).
A. Kawai and F. E. Yates. Interference with feedback inhibition of adrenocorticotropin release by protein binding of corticosterone.Endocrinology 79:1040–1046 (1965).
B. Koch, B. Lutz, G. Schmitt, and C. Mailhe. Influence of transcortin on degradation and tissue uptake of corticosterone in the infant rat.Horm. Metab. Res. 2:292–297 (1970).
M. Lippman and E. B. Thompson. The role of transcription in glucocorticoid mediated enzyme induction: Tyrosine aminotransferase induction in hepatoma tissue culture cells.J. Steroid Biochem. 5:461–465 (1974).
W. Rosner. Recent studies on the binding of cortisol in serum.J. Steroid Biochem. 3:531–542 (1972).
G. P. Lewis, W. J. Jusko, C. W. Burke, and L. Graves. Prednisolone side-effects and serum protein levels.Lancet 2:778–781 (1971).
P. L. Ballard. Delivery and transport of glucocorticoids to target cells.Monogr. Endocrinol. 12:25–48 (1971).
A. Munck and T. Brink-Johnsen. Specific and nonspecific physiochemical interactions of glucocorticoids and related steroids with rat thymus cellsin vitro.J. Biol. Chem. 243:5556–5565 (1968).
E. Bloom, D. T. Matulich, N. C. Lan, S. J. Higgins, S. S. Simons, and J. D. Baxter. Nuclear binding of glucocorticoid receptors: Relations between cytosol binding, activation and the biological response.J. Steroid Biochem. 12:175–184 (1980).
A. Munck and W. J. Holbrook. Glucocorticoid-receptor complexes in rat thymus cells.J. Biol. Chem. 259:820–831 (1984).
P. A. Bell and A. Munck. Steroid-binding properties and stabilization of cytoplasmic glucocorticoid receptors from rat thymus cells.Biochem. J. 136:97–107 (1973).
J. A. Goidl, M. H. Cake, K. P. Dolan, L. G. Parchman, and G. Litwack. Activation of the rat liver glucocorticoid-receptor complex.Biochemistry 16:2125–2130 (1977).
H. M. Westphal and M. Beato. The activated glucocorticoid receptor of rat liver.Eur. J. Biochem. 106:395–403 (1980).
M. Koblinsky, M. Beato, M. Kalimi, and P. Feigelson. Glucocorticoid binding proteins of rat liver cytosol. II. Physical characterization and properties of the binding proteins.J. Biol. Chem. 247:7897–7904 (1972).
A. Munck, C. Wira, D. A. Young, K. M. Mosher, C. Hallahan, and P. A. Bell. Glucocorticoid-receptor complexes and the earliest steps in the action of glucocorticoids on thymus cells.J. Steroid Biochem. 3:567–578 (1972).
J. L. Middlebrook, M. D. Wong, D. N. Ishii, and L. Aronow. Subcellular distribution of glucocorticoid receptors in mouse fibroblasts.Biochemistry 14:180–186 (1975).
M. Izawa, Y. Satoh, and S. Ichii. Recycling of steroid hormones. In H. Imura and H. Kuzuya (eds.),Hormone Receptors and Receptor Diseases, Excerpta Medica, Amsterdam, 1983, pp. 127–135.
W. R. McIntyre and H. H. Samuels. Triamcinolone acetonide regulates glucocorticoidreceptor levels by decreasing the half-life of the activated nuclear-receptor form.J. Biol. Chem. 260:418–427 (1985).
F. D. Boudinot. The role of protein binding in prednisolone pharmacodynamics. Ph.D. thesis, State University of New York at Buffalo (1986).
H. G. Morris. Mechanisms of action and therapeutic role of corticosteroids in asthma.J. Allergy Clin. Immunol. 75:1–13 (1985).
Author information
Authors and Affiliations
Additional information
Supported in part by grant GM 24211 from the National Institutes of General Medical Sciences, NIH.
Rights and permissions
About this article
Cite this article
Boudinot, F.D., D'Ambrosio, R. & Jusko, W.J. Receptor-mediated pharmacodynamics of prednisolone in the rat. Journal of Pharmacokinetics and Biopharmaceutics 14, 469–493 (1986). https://doi.org/10.1007/BF01059656
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01059656